“Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling” (2024) Biomolecules and Biomedicine, 24(6), pp. 1606–1619. doi:10.17305/bb.2024.10328.